Towards a Future of Personalized Vaccinology: Study on Individual Variables Influencing the Antibody Response to the COVID-19 Vaccine
Overview
Authors
Affiliations
The COVID-19 pandemic has hugely impacted many different aspects of human health, and vaccination is one of the most effective weapons to manage it. However, many different factors, such as age, gender, comorbidities and lifestyles, play a role in the response to infections and vaccines. We carried out this study to evaluate the potential role played by some individual factors in the production of anti-COVID-19 antibodies in the light of personalized and future vaccinology. We conducted an observational study consisting of a retrospective phase, exploiting previous data about anti-COVID-19 antibody responses, with a prospective phase to investigate individual variables through the use of a questionnaire. The antibody response after the COVID-19 vaccination was inversely related to old age, increased BMI and the number of smoking years, while a positive correlation was found with moderate alcohol consumption and especially with circulating levels of vitamin D, as clearly shown by the multivariate regression analysis. Our study showed that a number of variables are involved in the COVID-19 vaccine antibody response. These findings are very important and can be considered in the light of a future and personalized vaccinology.
Editorial: design considerations for future personalized vaccination approaches.
Rahman M Nanomedicine (Lond). 2024; 20(4):329-334.
PMID: 39552583 PMC: 11812407. DOI: 10.1080/17435889.2024.2419816.
Li J, Xu J, Liu Y, Chen L, Yu L, Xiao X Hum Vaccin Immunother. 2024; 20(1):2389602.
PMID: 39171541 PMC: 11346555. DOI: 10.1080/21645515.2024.2389602.
Vaccinomics and adversomics: key elements for a personalized vaccinology.
Lagana A, Visalli G, Di Pietro A, Facciola A Clin Exp Vaccine Res. 2024; 13(2):105-120.
PMID: 38752004 PMC: 11091437. DOI: 10.7774/cevr.2024.13.2.105.
Effects of Influenza Vaccine on the Immune Responses to SARS-CoV-2 Vaccination.
Riccomi A, Trombetta C, Dorrucci M, Di Placido D, Sanarico N, Farchi F Vaccines (Basel). 2024; 12(4).
PMID: 38675807 PMC: 11054385. DOI: 10.3390/vaccines12040425.
Fedele G, Schiavoni I, Trentini F, Leone P, Olivetta E, Fallucca A Front Immunol. 2023; 14:1272119.
PMID: 38077369 PMC: 10698351. DOI: 10.3389/fimmu.2023.1272119.